Namita Mitra

Namita Mitra

BVSc Veterinary Sciences, MVSc Veterinary Microbiology, PhD Animal Biotechnology, ACVM Diplomate-Virology

After earning a bachelor’s degree in Veterinary Sciences and Animal Health  (BVSc) in 2007, Namita went on to pursue a Master of Veterinary Microbiology from GADVASU, India. Her Master’s research on the molecular and histopathological diagnosis of avian oncogenic viruses in poultry brought her two national awards.

See more

In 2013, she was conferred a doctoral degree in Animal Biotechnology that concluded with her research findings on expression profiling of apoptosis-associated genes in canine mammary tumors. Right after her graduation, Namita worked as Assistant Professor of Animal Biotechnology and taught the courses of Animal Cell Culture, Animal Genetic Engineering, and Molecular Immunology.

A year later, she moved to the USA and joined as a research assistant in the Kansas State Veterinary Diagnostic lab. There, she worked on next-generation sequencing and data analysis with an emphasis on viral metagenomics. Driven by her deep interest in virology, she studied for the ‘American College of Veterinary Microbiologists (ACVM) board exam’ and in Dec 2018,  she was awarded ACVM Virology- diplomate status by the board.

In 2019, she joined the center for genome architecture at Baylor College of Medicine, where she got the opportunity to work on two very diverse projects; one of which was focused on the development of NGS-based diagnostic for SARS-CoV-2, and the other was to understand the crucial part of CTCF transcription factor that potentially interacts with cohesin protein to form chromatin loops.

An author and co-author of many peer-reviewed articles and a reviewer herself, Namita enjoys editing and reviewing scientific documents. She is interested in science outreach to the general audience. At the same time, she intends to communicate novel scientific discoveries to researchers and academic professionals. In her spare time, she loves to read and spend time with her daughter and family.

See less

Articles from Namita Mitra

Red foxes susceptible to SARS-CoV-2 infection

Red foxes susceptible to SARS-CoV-2 infection

Study shows mRNA booster dose eliminates immune escape observed with SARS-CoV-2 Omicron

Study shows mRNA booster dose eliminates immune escape observed with SARS-CoV-2 Omicron

Evidence on intra-host recombination of SARS-CoV-2 during superinfection by Alpha and Epsilon variants in USA

Evidence on intra-host recombination of SARS-CoV-2 during superinfection by Alpha and Epsilon variants in USA

New research on SARS-CoV-2 Omicron and care home residents

New research on SARS-CoV-2 Omicron and care home residents

Study evaluates socio-economic burden imposed on Chinese healthcare system during COVID

Study evaluates socio-economic burden imposed on Chinese healthcare system during COVID

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

Gaseous ozone is effective for SARS-CoV-2 disinfection

Gaseous ozone is effective for SARS-CoV-2 disinfection

Mutations in SARS-CoV-2 Omicron variant promote cell binding

Mutations in SARS-CoV-2 Omicron variant promote cell binding

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.